Abstract

A series of six novel benzimidazole-pyrazole hybrid molecules was synthesized and characterized using elemental analysis (CHN) and spectroscopic methods (1HNMR, FT-IR). All the synthesized compounds were evaluated for their in vivo anti ulcerogenic activity using Albino rats (weighing 180–220 g). The interactions between the compounds and active site residues of H+/K+ ATPase were investigated by molecular docking studies using autodock vina 4.0. SCH28080 was used to validate the docking results. Also the drug likeliness of these compounds was predicted using Molinspiration server in light of Lipinski’s rule of five. All the six synthesized compounds exhibited higher anti-ulcer activity as compared to omeprazole. These novel hybrid compounds showed comparable anti-ulcer potential of 72–83% at dose level of 500 µg/kg, whereas omeprazole showed 83% anti-ulcer activity at dose level of 30 mg/kg. The results clearly indicate that these novel benzimidazole-pyrazole hybrids can present a new class of potential anti ulcer agents and can serve as new anti-ulcer drugs after further investigation.Graphical abstractAn overveiw of synthesis, in silico and in vivo antiulcer screening of benzimidazole pyrazole hybrids

Highlights

  • Peptic ulcer disease is one of the ailments that influence numerous people around the globe in the developing world [1]

  • Chemistry As shown in scheme, the benzimidazole-Pyrazole 5 (a–f ) hybrids were prepared by three step synthesis starting from 2-mercaptobenzimidazole 1

  • All the compounds were purified by recrystallization in suitable solvents

Read more

Summary

Introduction

Peptic ulcer disease is one of the ailments that influence numerous people around the globe in the developing world [1]. About 10% of the world population is affected. As a consequence of peptic ulcer about 15,000 deaths occurs annually [2]. Certain aggressive and protective factors affect the acid release in gastrointestinal tract. Any imbalance in these factors may disrupt the mucosal protection and expose gastrointestinal lining to gastric acid leading to the lesions called ulcers [3]. Various medications including proton pump inhibitors and ­H2 receptor antagonist are available for the treatment of gastric ulcers, clinical assessment of these medications have demonstrated side effects, incidence of relapses and drug interactions [4] there is need

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.